<DOC>
	<DOCNO>NCT00410709</DOCNO>
	<brief_summary>This open label , single center , single dose PK study NatrOVA Creme Rinse ( 1 % ) , investigational treatment head louse nit , normal , healthy infant .</brief_summary>
	<brief_title>A Pharmacokinetic ( PK ) Study NatrOVA Topical Creme ( 1 % ) Pediatric Subjects 6 24 Months Age</brief_title>
	<detailed_description>There million child adult affect head louse year United States . It become major nuisance school child result many lose school day frustrate parent . Lice nit resistance current OTC product widely report . Compliance product instruction think low . Therefore safe effective alternative product desirable . Spinosad ( active ingredient NatrOVA ) formulation approve agricultural insecticide US , Canada Australia , receive provisional approval UK , Spain several European Union country . Spinosad formulate creme rinse product ( NatrOVA ) use excipients widely use `` generally regarded safe '' ( GRAS ) This study intend measure absorption ( lack thereof ) Spinosad scalp infant age 6 24 month , well observe adverse event relate use study drug . A validated method determining level Spinosad plasma utilize .</detailed_description>
	<mesh_term>Lice Infestations</mesh_term>
	<criteria>1 . Male female , 6 24 month age 2 . Individuals good general health , free systemic dermatologic disorder interfere study result . 3 . Completion appropriate Informed Consent Agreement . 4 . Subjects must available stay clinic blood draw . Parents guardian must available stay clinic minor subject , duration study . 5 . Subjects must vein capable withstand multiple blood draw . 6 . Normal value ( screen ) serum chemistry hematology subject . 1 . History irritation sensitivity pediculicide hair care product ingredient . 2 . History know allergy sensitivity topical anesthetic include lidocaine prilocaine . 3 . Systemic disease could interfere result study . 4 . Any condition illness , opinion Principal Investigator designee , may compromise objectivity protocol safety subject . 5 . The use antibiotic systemic medication within two week screen visit , opinion investigator , could interfere outcome study . 6 . Participation previous drug study within past 30 day . 7 . Individuals visible skin/scalp condition treatment site interfere evaluation accord opinion Investigator . 8 . Parents guardian , opinion Investigator , understand child 's requirement study participation and/or may likely exhibit poor compliance .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Pediculosis Capitis</keyword>
	<keyword>Head Lice</keyword>
	<keyword>Crawlers</keyword>
	<keyword>Ova</keyword>
	<keyword>Nits</keyword>
</DOC>